Skip to main content
. 2014 Feb 10;2014(2):CD003047. doi: 10.1002/14651858.CD003047.pub3
Database Time span Search strategy
Cochrane Hepato‐Biliary Group Controlled Trials Register January 2014. (dopa* OR 'dopa decarboxylase' OR levodopa OR bromocriptine) AND ('liver cirrhosis' OR 'hepatic encephalopathy')
The Cochrane Central Register of Controlled Trials (CENTRAL) Issue 12 of 12, 2013. #1 MeSH descriptor: [Dopamine Agents] explode all trees
#2 MeSH descriptor: [Dopa Decarboxylase] explode all trees
#3 MeSH descriptor: [Levodopa] explode all trees
#4 MeSH descriptor: [Bromocriptine] explode all trees
#5 dopa* or dopa decarboxylase or levodopa or bromocriptine
#6  #1 or #2 or #3 or #4 or #5
#7 MeSH descriptor: [Liver Cirrhosis] explode all trees
#8 MeSH descriptor: [Hepatic Encephalopathy] explode all trees
#9 (liver cirrhosis or hepatic encephalopathy)
#10 #7 or #8 or #9
#11 #6 and #10
MEDLINE (Ovid SP) 1946 to January 2014. 1. exp Dopamine Agents/
2. exp Dopa Decarboxylase/
3. exp Levodopa/
4. exp Bromocriptine/
5. (dopa* or dopa decarboxylase or levodopa or bromocriptine).mp. [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract, name of substance word, subject heading word, unique identifier]
6. 1 or 2 or 3 or 4 or 5
7. exp Liver Cirrhosis/
8. exp Hepatic Encephalopathy/
9. (liver cirrhosis or hepatic encephalopathy).mp. [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract, name of substance word, subject heading word, unique identifier]
10. 7 or 8 or 9
11. 6 and 10
12. (random* or blind* or placebo* or meta‐analysis).mp. [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract, name of substance word, subject heading word, unique identifier]
13. 11 and 12
EMBASE (Ovid SP) 1974 to January 2014. 1. exp dopamine receptor stimulating agent/
2. exp dopamine receptor blocking agent/
3. exp aromatic levo amino acid decarboxylase/
4. exp LEVODOPA/
5. exp BROMOCRIPTINE/
6. (dopa* or dopa decarboxylase or levodopa or bromocriptine).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer]
7. 1 or 2 or 3 or 4 or 5 or 6
8. exp liver cirrhosis/
9. exp hepatic encephalopathy/
10. (liver cirrhosis or hepatic encephalopathy).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer]
11. 8 or 9 or 10
12. 7 and 11
13. (random* or blind* or placebo* or meta‐analysis).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer]
14. 12 and 13
Science Citation Index‐Expanded (http://apps.webofknowledge.com) 1900 to January 2014. #5 20 #4 AND #3
#4 1,186,796 TS=(random* or blind* or placebo* or meta‐analysis)
#3 205 #2 AND #1
#2 54,464 TS=(liver cirrhosis or hepatic encephalopathy)
#1 198,470 TS=(dopa* or dopa decarboxylase or levodopa or bromocriptine)